Key1 Capital

Activity from announced rounds

All recorded activity

Key1 Capital is an Israeli growth-technology manager whose investment records identify Lyte, Remepy and Xsight.

Recorded funding activity

Lyte develops robotic perception systems. Remepy combines prescription medicines with therapeutic software, while Xsight designs connectivity chips for computing infrastructure. The companies pursue distinct hardware and healthcare products.

Sources
Rounds participated in
6
Confirmed lead rounds
0
3 roles undisclosed
New companies
5
First participation on record · 1 follow-on
Funding in participating rounds
$598M
5 disclosed · full round size, not this investor’s share

By stage

Series C+3
Growth1
Series A1
Undisclosed1

By primary sector

AI2
Hardware2
Biotech1
Cybersecurity1

By country

United States5
Israel1

Rounds

6 in all activity
Sentra

Sentra provides enterprise data security software that discovers sensitive information, maps access and governs what people, applications and AI agents can reach.

$150MSeries C
Participant
Lyte

Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.

$165MSeries C
Participant
Remepy

Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps

$36MSeries A
Role not disclosed
Xsight Labs

Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers

>$300MGrowth
Role not disclosed
Lyte

Lyte develops perception systems for robots and autonomous machines used in inspection, logistics and manufacturing.

$107MUndisclosed
Role not disclosed
WEKA

WEKA develops data infrastructure software for AI and other performance-intensive computing workloads.

$140MSeries E, combined primary and secondary transaction
Participant